Form D Explorer

Source evidence

Ensho Therapeutics, Inc. · 0002032849-26-000002

D filed Oct. 15, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
Woodcliff Lake
street1
50 Tice Boulevard
street2
Suite 340 - #1005
zipCode
07677
entityName
Ensho Therapeutics, Inc.
entityType
Corporation
stateOrCountry
NJ
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold7281948number7281948/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount15604179number15604179/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment1number1/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count7number7/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: 29f882f0679f3f27f03fa69cd5b11df842d04a282f5dbc89134bbd6895f163e0. This proves extraction identity, not the accuracy of the filer's claims.